{"pmid":32416526,"title":"Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic.","text":["Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic.","Diabetes Metab Syndr","Ghosh, Amerta","Dutta, Koel","Tyagi, Kanika","Gupta, Ritesh","Misra, Anoop","32416526"],"journal":"Diabetes Metab Syndr","authors":["Ghosh, Amerta","Dutta, Koel","Tyagi, Kanika","Gupta, Ritesh","Misra, Anoop"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32416526","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.dsx.2020.05.010","keywords":["covid-19","diabetes","telemedicine"],"locations":["India"],"countries":["India"],"countries_codes":["IND|India"],"topics":["Prevention"],"weight":1,"_version_":1666994545970118656,"score":9.490897,"similar":[{"pmid":32397895,"title":"COVID-19 and Diabetes-A View From India.","text":["COVID-19 and Diabetes-A View From India.","COVID - 19 has been one of the greatest disasters in human history. It has completely disrupted our lives. With regard to medical practice, it changed the way doctors started treating patients. One of the positives of COVID - 19 has been the emergnece of telemedicine in treating chronic conditions like diabetes. In India, telemedicine which was illegal was rapidly legalised and gudelines for telemedicine were drawn up. This commentay describes our approach to treating diabetes patiens during the COVID lockdown period based on experience at a large tertiary diabetes centre in India.","J Diabetes Sci Technol","Mohan, Viswanathan","32397895"],"abstract":["COVID - 19 has been one of the greatest disasters in human history. It has completely disrupted our lives. With regard to medical practice, it changed the way doctors started treating patients. One of the positives of COVID - 19 has been the emergnece of telemedicine in treating chronic conditions like diabetes. In India, telemedicine which was illegal was rapidly legalised and gudelines for telemedicine were drawn up. This commentay describes our approach to treating diabetes patiens during the COVID lockdown period based on experience at a large tertiary diabetes centre in India."],"journal":"J Diabetes Sci Technol","authors":["Mohan, Viswanathan"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32397895","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1177/1932296820928108","keywords":["covid 19","diabetes","teleconsultation","telemedicine"],"locations":["India","India","India"],"countries":["India"],"countries_codes":["IND|India"],"topics":["Prevention"],"weight":1,"_version_":1666714494831689728,"score":86.626854},{"pmid":32482098,"title":"COVID-19 Pandemic Triggers Telemedicine Regulation and Intensifies Diabetes Management Technology Adoption in Brazil.","text":["COVID-19 Pandemic Triggers Telemedicine Regulation and Intensifies Diabetes Management Technology Adoption in Brazil.","J Diabetes Sci Technol","Teles, Milena","Sacchetta, Teresa","Matsumoto, Yuri","32482098"],"journal":"J Diabetes Sci Technol","authors":["Teles, Milena","Sacchetta, Teresa","Matsumoto, Yuri"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32482098","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1177/1932296820930033","keywords":["covid-19","artificial intelligence","diabetes","digital health","pandemic","telemedicine"],"locations":["Brazil"],"countries":["Brazil"],"countries_codes":["BRA|Brazil"],"topics":["Prevention"],"weight":1,"_version_":1668704334445019136,"score":80.247406},{"pmid":32475168,"title":"COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.","text":["COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.","J Diabetes Sci Technol","Ceriello, Antonio","Schnell, Oliver","32475168"],"journal":"J Diabetes Sci Technol","authors":["Ceriello, Antonio","Schnell, Oliver"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32475168","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1177/1932296820930025","keywords":["covid-19","sars -cov-2","continuous glucose monitoring","diabetes","glucose variability","intensive care unit","telemedicine"],"topics":["Treatment","Prevention"],"weight":1,"_version_":1668437834945527808,"score":70.63115},{"pmid":32434606,"title":"ADHD and Covid-19: Current roadblocks and future opportunities.","text":["ADHD and Covid-19: Current roadblocks and future opportunities.","Attention Deficit Hyperactivity Disorder is the commonest disorder presenting to Child and Adolescent Mental Health Services in Ireland. ADMiRE is a specialist ADHD service in South Dublin that provides assessment and intervention for >200 children and adolescents with ADHD.The first section of this article considers the impact of the Covid-19 pandemic on the provision of mental health services for young people with ADHD with specific reference to the difficulties that have been experienced in ADMiRE since the outbreak of Covid-19 in Ireland. In ADMiRE, there has been a significant reduction of face to face consultations, postponement of new assessments, difficulties with physical monitoring, delays in medication initiation, suspension of medication titration, lack of group interventions and problems with access to controlled drug prescriptions. Current guidelines and alternative ways of ensuring adequate service provision are discussed.Restrictions to mitigate the spread of Covid-19 are likely to continue for many months, and child and adolescent mental health services need to find new ways to provide a sustainable service to young people in Ireland. There is a growing evidence base for telepsychiatry, the use of technology such as video conferencing to deliver mental health care remotely, and this approach may be particularly useful in assessment and management of ADHD. The second section of this article discusses the evidence base for telepsychiatry in ADHD, and outlines factors that should be considered when developing a telepsychiatry service for children and adolescents with ADHD.","Ir J Psychol Med","McGrath, Jane","32434606"],"abstract":["Attention Deficit Hyperactivity Disorder is the commonest disorder presenting to Child and Adolescent Mental Health Services in Ireland. ADMiRE is a specialist ADHD service in South Dublin that provides assessment and intervention for >200 children and adolescents with ADHD.The first section of this article considers the impact of the Covid-19 pandemic on the provision of mental health services for young people with ADHD with specific reference to the difficulties that have been experienced in ADMiRE since the outbreak of Covid-19 in Ireland. In ADMiRE, there has been a significant reduction of face to face consultations, postponement of new assessments, difficulties with physical monitoring, delays in medication initiation, suspension of medication titration, lack of group interventions and problems with access to controlled drug prescriptions. Current guidelines and alternative ways of ensuring adequate service provision are discussed.Restrictions to mitigate the spread of Covid-19 are likely to continue for many months, and child and adolescent mental health services need to find new ways to provide a sustainable service to young people in Ireland. There is a growing evidence base for telepsychiatry, the use of technology such as video conferencing to deliver mental health care remotely, and this approach may be particularly useful in assessment and management of ADHD. The second section of this article discusses the evidence base for telepsychiatry in ADHD, and outlines factors that should be considered when developing a telepsychiatry service for children and adolescents with ADHD."],"journal":"Ir J Psychol Med","authors":["McGrath, Jane"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32434606","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1017/ipm.2020.53","keywords":["adhd","attention deficit hyperactivity disorder","child and adolescent psychiatry","coronavirus","covid-19","ireland","telemedicine","telemental health","telepsychiatry"],"locations":["Ireland","South Dublin","Ireland","Ireland"],"countries":["Ireland"],"countries_codes":["IRL|Ireland"],"weight":0,"_version_":1667521393832493056,"score":69.11313},{"pmid":32486900,"title":"Inpatient Diabetes Management During the COVID-19 Crisis: Experiences From Two Community Hospitals.","text":["Inpatient Diabetes Management During the COVID-19 Crisis: Experiences From Two Community Hospitals.","J Diabetes Sci Technol","Shelton, Carter","Demidowich, Andrew P","Zilbermint, Mihail","32486900"],"journal":"J Diabetes Sci Technol","authors":["Shelton, Carter","Demidowich, Andrew P","Zilbermint, Mihail"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32486900","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1177/1932296820930268","keywords":["community hospital","diabetes","inpatient","management","telehealth","telemedicine"],"topics":["Prevention"],"weight":1,"_version_":1668892169356705792,"score":66.727356}]}